Because the liver can lose most of its function before warning signs appear, tracking MELD score trends and exploring transplant and living donor options early gives patients safer choices than waiting for a crisis.
Despite significant progress in diagnosis and treatments, hepatocellular carcinoma (HCC), often diagnosed at late stages, remains a life-threatening disease with an increasing incidence.
Researchers have unveiled the RNF41 protein as a potential new therapeutic target in the battle against two chronic liver diseases: cirrhosis and liver inflammation.
Just over a century has passed since the discovery of insulin, a time period during which the therapeutic powers of the hormone have broadened and refined.